• Join
  • Login
  • Contact

Search abstracts

The virtue of translational toxicology in drug discovery: selecting the right cinical candidate while reducing risk

  • In: SHOWCASE CHINA on Wednesday, 16 April 2014, 16:00-17:20
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Presentation
  • By: JIN, Ren (Shanghai Institute of Materia Medica, Center for drug safety evaluation and research, Shanghai, China)
  • Abstract:

    I. Background: Drug discovery is cost, time and risk intensive process. It takes ~one billion dollars and about 10-15 years to bring drug from concept to clinic. The majority of compounds do not progress from laboratory to patients, only 20% of the product enters the phase I trials eventually cleared the obstacle of FDA approval. The high..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses